Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Interim Management Statement

17 Oct 2013 14:39

RNS Number : 7890Q
Maven Income and Growth VCT 3 PLC
17 October 2013
 

 

Maven Income and Growth VCT 3 PLC (the Company)

 

Interim Management Statement - quarter ended 31 August 2013

 

This Interim Management Statement, for the quarter ended 31 August 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 September 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 80.95p per share at 31 August 2013, after payment of the interim dividend, compared to 82.60p per share at 31 May 2013;

· NAV total return2 of 117.40p at 31 August 2013, compared to 117.05p at 31 May 2013; and

· Interim dividend of 2.00p per share in respect of the year ending 30 November 2013, paid on 30 August 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 August 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 May 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 31 August 2013, six new and four follow-on investments totalling a net amount of £3,635,284 were made in unlisted companies. In the same period, disposals from three unlisted company investments generated aggregate proceeds of £375,726 against a cost of £508,491; disposals of four AIM quoted investments generated aggregate proceeds of £173,247 against a cost of £269,513; and proceeds of £1,249,942 were realised from the sale of UK Government Securities.

 

3.

Recent developments

 

Between 1 September 2013 and the date of this Statement, two follow-on investments in unlisted companies totalling £86,952 were made and the disposal of an AIM quoted investment generated proceeds of £37,181 against a cost of £33,804. There was also a return of capital of £360,000 from an unlisted company investment.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 June 2013 to 31 August 2013, or in the period from 1 September 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

17 October 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMMGFNNGFZM
Date   Source Headline
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
8th Apr 202012:38 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update & Suspension of DIS
19th Mar 20204:30 pmRNSAGM Update – Notification of Change of Venue
10th Mar 20204:41 pmRNSAnnual Financial Report
19th Feb 20204:09 pmRNSTransaction in Own Shares
5th Feb 202010:36 amRNSDirector/PDMR Shareholding
5th Feb 202010:32 amRNSIssue of Equity
28th Jan 202011:40 amRNSStatement re Offer for Subscription
20th Jan 20205:12 pmRNSTransaction in Own Shares
17th Jan 20204:45 pmRNSTransaction in Own Shares
17th Jan 202012:22 pmRNSNet Asset Value and Proposed Final Dividend
10th Dec 201912:28 pmRNSResult of General Meeting
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
20th Nov 20194:26 pmRNSTransaction in Own Shares
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
24th Oct 20194:06 pmRNSTransaction in Own Shares
23rd Oct 20194:43 pmRNSNet Asset Value(s)
2nd Sep 20193:34 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:26 pmRNSIssue of Equity
30th Aug 20194:27 pmRNSNet Asset Value(s)
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
26th Jul 201911:25 amRNSHalf-year Report
10th Jul 20195:03 pmRNSTransaction in Own Shares
2nd Jul 20194:20 pmRNSUnaudited Net Asset Value and Interim Dividend
28th May 20193:13 pmRNSTransaction in Own Shares
11th Apr 201910:53 amRNSNet Asset Value(s)
10th Apr 201912:49 pmRNSResult of AGM
1st Mar 20193:01 pmRNSAnnual Financial Report
7th Feb 20194:34 pmRNSTransaction in Own Shares
17th Jan 20193:06 pmRNSNet Asset Value(s)
27th Nov 20182:42 pmRNSTransaction in Own Shares
21st Nov 20184:03 pmRNSNet Asset Value(s)
20th Jul 20184:04 pmRNSHalf-year Report
17th Jul 20184:09 pmRNSTransaction in Own Shares
3rd Jul 20184:30 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:49 pmRNSStatement re DIS
17th May 20184:30 pmRNSDividend Declaration
26th Apr 20189:35 amRNSDirector/PDMR Shareholding
24th Apr 20184:51 pmRNSIssue of Equity
16th Apr 20185:12 pmRNSNet Asset Value(s)
13th Apr 201812:47 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
11th Apr 20181:12 pmRNSResult of AGM
6th Apr 20184:38 pmRNSStatement re Dividend Investment Scheme
6th Apr 20189:21 amRNSDirector/PDMR Shareholding
5th Apr 20186:22 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.